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ABSTRAK
Latar belakang: Pegagan telah digunakan untuk pengobatan diabetes mellitus. Namun dosis efek anti-
diabetes ini belum diteliti.
Tujuan: Untuk menguji pengaruh variasi dosis ekstrak pegagan (seluruh bagian tanaman) terhadap 
kadar gula darah, asupan makanan, dan berat badan pada tikus model diabetes mellitus yang diinduksi 
Streptozotocin Nicotinamide.
Metode: Tiga puluh enam tikus Wistar jantan dibagi menjadi enam kelompok perlakuan berbeda: kontrol 
negatif, kontrol positif, kontrol obat (metformin 45 mg/KgBB/hari), ekstrak pegagan 300 mg/KgBB/hari, 600 
mg/KgBB/hari, 1200 mg / KgBB / hari. Pemberian ekstrak pegagan (seluruh bagian tanaman) dan metformin 
dilakukan selama 28 hari. Kadar gula darah dianalisis menggunakan Glucose Oxidase Phenol Aminoantipyrina 
Peroxidase (GOD-PAP) sebelum dan sesudah perlakuan. Berat badan dan asupan makanan diukur 
setiap satu minggu. Data dianalisis menggunakan One Way ANOVA dengan tingkat kepercayaan 95%.
Hasil: Pemberian variasi dosis ekstrak pegagan dan metformin secara signifi kan menurunkan kadar gula 
darah, meningkatkan berat badan dan memperbaiki asupan makanan (p = 0,00). Kadar gula darah dan 
asupan makanan pada kelompok ekstrak pegagan (seluruh bagian tanaman) dosis tinggi  (1200 mg / KgBB 
/ hari) lebih baik dibanding kelompok dosis rendah (300 mg / KgBB / hari) dan kelompok dosis sedang (600 
mg / hari), dan memiliki efek yang sama dengan tikus yang diobati dengan metformin 45 mg / KgBB / hari.
Kesimpulan: Dosis tinggi ekstrak pegagan (1200 mg/KgBB/hari) memiliki efek anti-diabetes 
yang lebih baik dibanding dosis lain, dan memiliki efek yang sama dengan kontrol obat.
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ABSTRACT
Background: Centella asiatica has been used for healing diabetes mellitus. The dosage of this anti-
diabetic effect was yet to be explored. 
Objectives: To examine the effect of the variation in the dosage of C. asiatica extract (whole plant) on 
blood glucose levels, food intake, and body weight in Streptozotocin Nicotinamide induced diabetic rats. 
Methods: Thirty-six male Wistar rat were divided into six different groups of treatments: negative control, 
positive control, medication control (metformin 45 mg/KgBW/day), extract of C. asiatica 300 mg/KgBW/day, 
600 mg/KgBW/day, 1200 mg/KgBW/day. Treatments of C. asiatica extract (whole plant) and metformin 
was done for 28 days. Blood glucose was analyzed using the Glucose Oxidase Phenol Aminoantipyrina 
Peroxidase (GOD-PAP) before and after treatment. Body weight and food intake were measured every 
one week. The data were analyzed using One Way ANOVA with 95% confi dence level.
Results: The administration of the variation in the dosage of C. asiatica extract and metformin signifi cantly 
decrease blood glucose levels, increase body weight and improve food intake (p =0.00). Blood glucose 
level and food intake among high dosage of C. asiatica extract (whole plant) group (1200 mg/KgBW/day) 
is better than the low dosage group (300 mg/KgBW/day) and moderate dosage group (600 mg/KgBW/
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anti-diabetes (13-15). C. asiatica contains a high 
level of antioxidant from the group of pentacyclic 
triterpenoids (asiatic acid, made classic acid, 
asiaticoside, and madecassoside) (16-19). The 
content of triterpenoid contained in C. asiatica 
is known to improve glucose response through 
increased protein GLUT4 muscle, IR, IRS 1, and 
IRS 2 (20-24).
The use of C. asiatica extract as the herb 
availability has more positive sides such as 
effective, relatively cheaper, low level of side 
effects, and low level of toxicity (20). The use of 
triterpene marker on the extract of C. asiatica is 
more effective to the T2D patients in increasing 
the secretion of the insulin compared to the anti-
diabetes oral medicine (21. 25-27). The use of 
Ethanol extract of the C. asiatica leaves, a dosage 
of 300 mg/KgBW/day for 28 days is proven in 
normalizing the level of blood glucose in Type 2 
Diabetic Model Rats – the induction of high-fat 
diet and the Streptozotocin, but the use of the 
variation in the dosage (300, 600, 1200 mg/KgBW/
day) of ethanol extract from all parts of C. asiatica 
(roots, stems and leaves) to blood glucose levels, 
body weight and feed intake in the type 2 diabetic 
model rats–streptozotocin-nicotinamide (STZ-
NA) induced diabetic rats is unknown. Therefore, 
the aims of this study are to evaluate the effect 
of C. asiatica extract as anti-diabetic to blood 
glucose levels, body weight and feed intake in 
Streptozotocin-Nicotinamide (STZ-NA) induced 
diabetic rats.  
MATERIALS AND METHODS
This study was experimental research with 
the randomized post-test only with controlled group 
design. The study was conducted from March to 
September 2017. The whole methods that were 
used had been approved by the Health Research 
Ethics Committee Dr. Moewardi General Hospital 
INTRODUCTION
Diabetes Mellitus (DM) is a metabolic disorder 
that becomes the main problem of the health in 
all around the world, the prevalence in the world 
reaches the number of 382 million people and it 
is estimated to increase into 592 million people 
by 2035, while in Indonesia the patients of DM 
increases from 1.1 percent (1.1 %) in 2007, to 2.1% 
in 2013 on the basic health research (IDF, 2014; 
Ministry of Health, 2013).
Type 2  Diabetes Mellitus (T2DM) is a complex 
metabolic disorder that is marked with the case of 
hyperglycemia as a result of the failure of cell β 
pancreas so that there is a resistance for the insulin 
(3). T2DM happens because of the disturbance 
of the progressive insulin secretion that becomes 
the main problem of a resistance to the insulin (4). 
Severe hyperglycemia and the disturbance of the 
insulin secretion cause several indications such as 
polyuria, polydipsia, polyphagia, and the loss of 
weight (5, 6). Severe hyperglycemia that happens 
to T2DM patients may poison the cell β pancreas 
with the glucose and the patients may have the 
apoptosis (7,8).
The anti-diabetes oral therapy plays an 
important role in controlling the level of the blood 
glucose. However, some researchers show that 
the use of anti-diabetes therapy can cause several 
side effects such as nauseous, digestion disorder, 
and diarrhea. Furthermore, if the therapy is used in 
a long-term, it can cause the other side effects such 
as the defi ciency of vitamin B12, and the raising of 
the risk of cancer (9-11).  
There is a raising of the demand for the herb 
availability from the plants that have the characteristic 
of antioxidant and anti-diabetes. Centella asiatica 
has been used as a traditional medicine (herbal 
medicine) in Indonesia and Asian countries since 
hundreds of years ago (12). C. asiatica is one of the 
herbs that have the characteristic of antioxidant and 
day), and have the same effect with the rats treated with metformin 45 mg/KgBW/day.
Conclusion: High dosage of C. asiatica extract (1200 mg/KgBW/day) had a better anti-diabetic effect 
than other dosages, and had the same effect with the medication control.
KEYWORDS: blood glucose, Centella asiatica, diabetes, nicotinamide, Streptozotocin
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and School of Medicine, Universitas Sebelas Maret 
(128/II/HREC/2017). 
The sample of C. asiatica was obtained from 
commercial products. C. asiatica was extracted with 
the ethanol of 70% (ChemPur, Karlsruhe, Germany) 
(28). T C. asiatica extract was made done at LPPT-
Unit 1 (Lembaga Penelitian dan Pengujian Terpadu) 
Universitas Gadjah Mada Yogyakarta – Unit 1. 
Thirty six male albino Wistar rats (Rattus 
norvegicus) in the age of 8—10 weeks in the body 
weight of 200 ± 50 gram were divided into 6 different 
groups of treatments:  
1. Negative control (standard feed- comfeed, 
aquades)
2. Positive control (standard feed- comfeed, 
aquades, STZ-NA) 
3. Medication control (standard feed- comfeed, 
aquades, STZ-NA, metformin 45 mg/KgBW/day)
4. CAE treatment dosage 1 (standard feed- 
comfeed, aquades, STZ-NA, CAE 300 mg/
KgBW/day)
5. CAE treatment dosage 2 (standard feed- 
comfeed, aquades, STZ-NA, CAE 600 mg/
KgBW/day) 
6. CAE treatment dosage 3 (standard feed- 
comfeed, aquades, STZ-NA, CAE 1200 mg/
KgBW/day) 
Animal breeding was attempted based on 
the modifi cation procedures by Nain et al. (2012) 
(29). Thirty six male Wistar rats were placed in a 
large hygienic polypropylene enclosure containing 
6 insulated rats, fi lled with one rat per bulkhead. The 
rats were maintained in a room with a temperature 
control (22±20 0C) 12 hours of bright light and 12 
hours dark cycle (lights turned on at 07.00 am), 
humidity 70 - 90%. The STZ-NA induction was 
performed on the modifi cation of the Ortiz-Andrade 
et al. (2008) with a dosage of streptozotocin 65 
mg/KgBW and nicotinamide 230 mg/KgBW, rats 
expressed hyperglycemia if the blood glucose level 
was ≥150 mg / dL (30). 
The measurement of glucose blood levels 
using the Glucose Oxidase Phenol Aminoantipyrina 
Peroxidase (GOD-PAP) method using Glucose 
GOD FS kit from Diagnostic System International 
(Diasys, Holzheim, Germany), was done before 
treatment and 28 days after the administration of 
C. asiatica extract. The measurements were made 
in the morning before feeding, blood samples were 
obtained from the orbital vein end. A total of ± 0.5 
ml of blood samples which were taken had been 
collected into Eppendorf, centrifuged for 10 minutes 
at 2500 rpm, the serum was taken and the enzymatic 
blood glucose levels were determined by GOD-PAP 
method (31).
Each rat was weighed by using digital scales 
and measured every seven days during the research. 
While the intake of feed in each week was calculated 
from the average total feed intake in one week (the 
feed gave minus the remaining feed) as measured 
using a digital scales. The maintenance and the 
manufacture of laboratory rats, the measurement of 
blood glucose levels, the body weight and the feed 
intake were done in Laboratorium Pusat Pangan dan 
Gizi PAU Universitas Gadjah Mada. The statistical 
analysis was performed using SPSS for Windows 
release 20.0. The data obtained were tested for 
normality using Shapiro-Wilk test and homogeneity 
using Levene’s test. The data variant is normally 
distributed and homogeneous such as blood glucose 
levels and the body weight, it is followed by the One-
Way ANOVA (Analysis of Varian) test to determine the 
average difference between the six groups, followed 
by the tukey high signifi cant difference (HSD) test to 
identify the different groups of names signifi cantly. The 
normality and homogeneity requirements of the data 
are not met such as feed intake, then a comparable 
nonparametric test is a Kruskal-Wallis test. If there 
are signifi cant differences, it will be continued with the 
Mann-Whitney test. The differences in blood glucose 
levels, weight, and feed intake before and after the 
treatment in all groups were tested for paired t-test. 
There is a signifi cant difference if p-value <0.05 (32).
RESULTS
Centella asiatica extract reduced blood glucose 
levels in STZ-NA induced diabetic rats
The analysis of blood glucose level before 
STZ-NA induction had a normal and homogeneous 
variation (p> 0.05). Measurement of rat blood 
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glucose level was done 3 times: before induced 
STZ-NA, three days after induction of STZ-NA, and 
28 days after treatment of C. asiatica extract dose 
300, 600 and 1200 mg/kgBW/day and metformin 
45 mg/KgBW/day which can be seen in Table 1.
The mean of the blood glucose levels before 
and after the treatment differed significantly 
(p=0.00). Giving ethanol extract of C.asiatica in the 
dosage of 300 mg/KgBW/day (P1), 600 mg/KgBW/
day (P2), 1200 mg/KgBW/day (P3) and metformin 
45 mg/KgBW/day (MC) was proven to be able to 
decrease the rat’s blood glucose levels signifi cantly 
(p =0.00). The result of the measurement of blood 
glucose level in the group treated with extract of 
C.asiatica in a dosage of 300 mg/KgBW/day (P1) 
showed that this treatment could decrease the 
blood glucose level signifi cantly (p=0.00) as much 
as 73.92 ± 4.16 mg / dL, but some rats still had the 
hyperglycemia (> 150 mg / dL) (Table 1).
Blood glucose levels of rats which were 
treated with the extracts of C.asiatica in the dosage 
of 600 mg/KgBW/day decreased and did not have 
hyperglycemia, but this condition was not in the 
normal category. The normal blood glucose level of 
rats is 50-135 mg / dL (40). The results of Tukey HSD 
test showed a decrease in blood glucose level of rats 
treated with extract of C.asiatica 1200 mg/KgBW/
day (P3), this was similar to the group that was given 
metformin 45 mg/KgBW/day (MC), and has reached 
the normal condition (Table 1). However, the effect 
of the decrease in the blood glucose level in the 
group with extract of C.asiatica 1200 mg/KgBW/
day (P3) was 126.36 ± 6.88 mg/dL, better than the 
medication control group (metformin 45 mg / Kg of 
body weight) 120.70 ± 6.65 mg/dL (Table 1).
Centella asiatica extract improved food intake 
in STZ-NA induced diabetic rats
The effect of the variation in the dosage of C. 
asiatica extract to food intake of rats can be seen 
in Table 2.
There was a signifi cant change in the rats’ 
feed intake before and after the treatment. However, 
based on Mann-Whitney’s further tests, it was known 
that the intake of feed before the administration of 
C. asiatica extract in the negative control group, the 
positive control group, treatment dosage 1, dosage 2 
and dosage 3 were the same. While the medication 
Table 1. Blood Glucose Level (mg/dl) before and after treatment
Group Pre test(mg/dL)
Post test
(mg/dL)
Difference (Δ)
(mg/dL)
Negative control 77.04 ± 3.33 a 79.63 ± 2.65 a -2.59 ± 1.29
Positive control 256.83 ± 7.27 bc 261.66 ± 8.69 b -4.83 ± 2.42
Medication control 253.28 ± 6.28 c 132.58 ± 4.10 e 120.70 ± 6.65
CAE 300mg/KgBW (Dosage 1) 261.78 ± 4.58 b 187.86 ± 1.89 c 73.92 ± 4.16
CAE 600 mg/KgBW (Dosage 2) 257.10 ± 7.10 bc 143.35 ± 2.23 d 113.75 ± 7.44
CAE 1200 mg/KgBW (Dosage 3) 257.56 ± 5.69 bc 131.21 ± 2.84 e 126.36 ± 6.88
n=6; CAE= Centella asiatica extract; Delta (Δ)= the difference of average blood glucose levels before and after 
the treatment 
a,b,c,d,e) Different notations indicated a signifi cant difference based on the One-Way Anova test (P < 0.05).
Tabel 2. Food intake (gram) before and after treatment
Group Pre test(gram)
Post test
(gram)
Negative control 12.67  ± 1.03 a 13.17  ± 0.75 a
Positive control 13.50  ± 0.055 a 14.00  ± 0.63 b
Medication control 12.33  ± 0.52 b 12.33  ± 0.78 e
CAE 300mg/KgBW (Dosage 1) 12.83  ± 1.17 a 12.17  ± 0.75 c
CAE 600 mg/KgBW (Dosage 2) 12.83  ± 0.41 ab 12.43  ± 0.84 d
CAE 1200 mg/KgBW (Dosage 3) 13.17  ± 0.75 a 13.00  ± 0.89 e
n=6; CAE= Centella asiatica extract; 
a,b,c,d,e) Different notations indicated a signifi cant difference based on the Kruskal Wallis test (P < 0.05).
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control group was different from the other groups, 
but the same as the treatment group dosage 2. It can 
be seen that the polyphagia conditions that occur 
in rats have not been maximized. However, after 
28 days there was an increase in feed intake in the 
positive control group and differed signifi cantly with 
the other groups, as well as proving the presence 
of polyphagia conditions (Table 2).
The mean feed intake before and after the 
treatment differed signifi cantly (p<0.05). There was 
a signifi cant decrease in intake of drug control rats, 
rats treated with extracts of C. asiatica dose 300 and 
1200 mg/KgBW/day, but in rats given C. asiatica 
extract dose 600 mg/KgBW/day increased feed intake. 
There was a signifi cant decrease in the intake of the 
same feed in the group of rats treated with C. asiatica 
extract in a dosage of 1200 mg/KgBW/day and given 
metformin of 45 mg/BW/ day (Table 2).
Centella asiatica extract increased body weight 
in STZ-NA induced diabetic rats
The development of body weight was 
monitored periodically; before the induction of 
STZ-NA, 3 days after the induction and declared as 
DM type 2 which was the beginning of the treatment 
day-0, day-7, day-14, day-21, and day-28 after 
treatment (Figure 1).
The results showed that in the negative control 
group, healthy rats had signifi cant weight gain in 
each week (p<0.05). After the induction of STZ-
NA, there was signifi cant weight loss in the positive 
group, medication control group, and treatment 
group. This indicates that the induction of STZ-NA 
causes weight loss in rats. After the treatment, 
the experimental group of C.asiatica extract and 
medication control group had significant weight 
gain until the end of the study (p<0.05). While in 
the positive control group, the group of untreated 
diabetic type 2 model rats experienced signifi cant 
weight loss each week (p=0.00). 
The mean weight of rats after the treatment for 
28 days of C. asiatica extract with 300 mg/KgBW/
day with a dosage of 1200 mg/KgBW/day, a dosage 
of 600 mg/KgBW/day with metformin 45 mg/KgBW/
day was the same as presented in Table 3.
DISCUSSION
The laboratory rats exper ienced the 
hyperglycemia 3 days after the induction of 
Streptozotocin-Nicotinamide (STZ-NA) with the 
blood glucose level > 150 mg / dL. There were no 
dead rats. This was due to the effect of Nicotinamide 
(NA) protection against excess cytotoxic β effects of 
STZ so that until the research was complete there 
were no dead rats even on the rats with the positive 
control (33).
Table 3. Body weight (gram) before and after treatment
Group Pre test(gram)
Post test
(gram)
Difference (Δ)
(gram)
Negative control 197.83 ± 7.36 a 229.83 ± 6.24 a -32.00 ± 1.79
Positive control 195.17 ± 6.82 ab 179.17 ± 6.01 b 16.00 ± 1.41
Medication control 188.17 ± 5.15 b 204.83 ± 5.27 c -16.67 ± 0.52
CAE 300mg/KgBW (Dosage 1) 189.67 ± 2.88 b 213.83 ± 2.48 d -24.17 ± 1.17
CAE 600 mg/KgBW (Dosage 2) 187.17 ± 2.32 b 207.83 ± 2.40 c -20.66 ± 0.52
CAE 1200 mg/KgBW (Dosage 3) 191.17 ± 3.06 b 215.17 ± 3.71 d -24.00 ± 0.89
n=6; CAE= Centella asiatica extract; Delta (Δ)= the difference of average blood glucose levels before and after 
the treatment 
a,b,c,d,e) Different notations indicated a signifi cant difference based on the One-Way ANOVA test (p < 0.05).
Figure. 1. The mean of body weight during 28 days
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The T2DM model rats were inducted by using 
Streptozotocin-Nicotinamide because it has several 
advantages: (1) stable moderate hyperglycemia 
that does not require exogenous insulin to survive; 
(2) decreased β-cell by 40% and decreased insulin 
production by 60% (3) glucose intolerance due to 
the impaired insulin secretion; (4) the presence of 
glucose-stimulated insulin secretion (though it was 
disturbed); and (6) weight loss, polyphagia and 
polydipsia (34).The giving of C. asiatica extract till 
the dosage of 1200 mg/KgBW for 28 days did not 
cause death in rats. This is in line with previous study 
in Rahman et al. (2012), the provision of C. asiatica 
extract up to a dosage of 3000 mg/KgBW/day in 
laboratory rats showed no signs of acute toxicity and 
death (35). Before the intake of C. asiatica extract 
was done (pretest), the mean of the blood glucose 
level of the treatment group that was given with C. 
asiatica extract was the same as the medication 
control group, and the positive control group (T2D 
control), but different from the negative control group 
(p=0.00) (Table 1). It was proved that before the 
treatment was carried out in the group of C. asiatica 
extract treatment and medication control group 
experienced the same hyperglycemia condition, 
same as the condition in the positive control group, 
and the making of type 2 diabetic model rats was 
successfully performed. The increasing of blood 
glucose levels (hyperglycemia) in type 2 diabetes 
occurred due to the energy metabolic disturbances 
(glucose absorption, glucose utilization, and TCA 
cycles), the increasing of gluconeogenesis (the 
increasing of endogenous glucose production) and 
glycogenolysis (36).
The giving of C. asiatica extract dosage 300 
mg/KgBW/day could decrease the blood glucose 
level but couldn’t reach the normal limit (>150 mg/
dL) (Table 1). This was not in line with the research 
of Maulidani et al. (2016) which states that the use 
of C. asiatica extract in a dosage of 300 mg/KgBW/
day for 28 days can normalize the blood glucose 
levels (37). The difference of the results of this 
study was possible because of the differences in the 
inductions that were given in the making of the T2D 
model rats, part of C.asiatica that was extracted and 
the origin of C.asiatica used. Part of C. asiatica that 
was extracted and the origin of C.asiatica (location 
and environmental condition of C.asiatica planted) 
is one of the factors that infl uence the quality and 
quantity of phenolic bioactive compounds and the 
C.asiatica’s triterpenoid (17,38,39). 
The giving of C. asiatica extract dosage 1200 
mg/KgBW/day could decrease the blood glucose 
level  equivalent to metformin. Centella asiatica is 
a herb that is used as a traditional medicine (herbal 
medicine) in Indonesia and Asian countries since 
hundreds of years ago (12). C.asiatica contains a 
variety of chemical components, but the most is the 
antioxidant component of the triterpenoid group. 
C.asiatica has higher antioxidant content (89%) 
when it is compared to grape seed (83%) and vitamin 
C (88%) (11,41). The results of the phytochemical 
test showed that C.asiatica contains the antioxidant 
of β-carotene, β-sitosterol, cholesterol, camphor, 
kaempferol, stigmasterol, fl avonoid saponin, and 
the largest are pentacyclic triterpenoid groups 
(asiatic acid, made classic acid, asiaticoside, and 
madecassoside) (16-19).
Triterpenoid contained in Centella asiatica 
is a compound that plays a role in lowering blood 
glucose levels by improving glucose response 
through increased protein GLUT4 muscle, IR, IRS 
1, and IRS 2 (20-24). Giving the C.asiatica extracts 
can restore changes in carbohydrate metabolism 
enzyme levels, prevent lipid peroxidation, increase 
antioxidant status, and increase fat metabolism 
enzymes, thus lowering blood glucose levels and 
increasing plasma insulin levels. (21,25,27).
Based on Table 2, it was known that there was 
a signifi cant change in the rats’ feed intake before 
and after the treatment. Polyphagia in T2D occurs 
due to the insulin in the blood is not enough to enter 
the blood glucose into the cell as a source of energy, 
thus causing the body always feel hungry (4). 
The giving of C. asiatica extract dosage 1200 mg/
KgBW/day could decrease equivalent to metformin 
(Table 2). A decrease in feed intake may be due 
to C. asiatica extract improves the polyphagia 
condition and increases rat’s leptin hormone. Leptin 
is a hormone involved in regulating weight, feed 
intake, and energy expenditure. Giving an ethanol 
extract of C. asiatica can decrease feed intake and 
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increase weight in laboratory animals that have 
leptin defi ciency (42).
Type 2 Diabetes Mellitus is a complex metabolic 
disorder that is marked with the case of hyperglycemia 
as a result of the failure of cell β pancreas so that 
there is a resistance for the insulin (3). T2D happens 
because of the disturbance of the progressive 
insulin secretion that becomes the main problem 
of a resistance to the insulin (4). Insulin secretion 
disorders lead to weight loss (5,6). The disturbance of 
insulin secretion causes the blood glucose disruption 
to enter the cells in the muscle and fat tissue so that 
the energy source is obtained from the splitting of 
stagnant energy that is reserved and from the fat tissue 
through glycogenolysis and lipolysis. The process of 
glycogenolysis and lipolysis that occur continuously 
causes the decrease of the mass of the muscle and 
fat tissue and leads to weight loss. (4).
The given of C. asiatica extract resulted in 
the same weight gain of rat’s as metformin (Table 
3). Weight gain occurs because C. asiatica extract 
has been shown to increase the levels of pyruvate, 
alanine, lactate, and crevice intermediate substances, 
leading to the increase of glycolysis, the decrease 
of gluconeogenesis and the increase of Kreb cycle’ 
(34). The administration of C. asiatica extract in T2D 
model rats was signifi cantly shown to restore the major 
enzyme activity in the increase of glycoses, such as 
hexokinase, glucose-6-phosphate dehydrogenase 
(G6PDH), and pyruvate kinase (PK) (11,21).
CONCLUSIONS AND RECOMMENDATIONS
The extracts of 1200 mg/KgBW/day of 
Centella asiatica had a better antidiabetic effect 
than dosage 300 and 600 mg/KgBW/day, and had 
the same effect with metformin 45 mg/KgBW/day. 
A similar study needs to be done but with longer 
hyperglycemia conditions before the treatment, so 
that the signs and symptoms of type 2 diabetes in 
rats are more visible. 
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